Floatz logo

Sulfadiazine

Radiation-Induced Dermatitis

OHSU Knight Cancer InstituteSmall moleculeN/AActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

11 Active assets in the Radiation-Induced Dermatitis cohort.

Asset / SponsorPhaseRating
BETAMETHASONE
Cairo University
Phase 4BB
Olea europaea oil
Cairo University
Phase 4BB
Urea
University of Brasilia
Phase 3BB
Mometasone
North Central Cancer Treatment Group
Phase 3BB
Chamomilla recutita
University of Brasilia
Phase 3BB

View all 33 →

Same molecule, other indications

Sulfadiazine is also rated in:

toxoplasmosisDormant
B
Indicative ·
62 / 100
View asset →
breast carcinomaDormant
D
Indicative ·
30 / 100
View asset →
head and neck carcinomaDormant
D
Indicative ·
30 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →